Evidence map›Paper›PMID 36624798›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2022

The Comparison of Clinical Epidemiology of Hospitalized Patients with COVID-19 during the Third and Fourth Waves of the Pandemic in Gorgan.

Samira Eshghinia, Rahmat Allah Sharifi Far, Naghimeh Hajimoradloo, Ali Sinesepehr, Ahmad Sohrsbi, Mousa Imeri, Amir Reza Khodanazar Kalti, Erfan Rezaie Shirazi, Roghieh Golsha

Open access · goldAbstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Samira EshghiniaBiochemistry and Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Rahmat Allah Sharifi FarInfectious Diseases Research Center, Golestan University of Medical Science, Gorgan, Iran.
Naghimeh HajimoradlooInfectious Diseases Research Center, Golestan University of Medical Science, Gorgan, Iran.
Ali SinesepehrSchool of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Ahmad SohrsbiInfectious Diseases Research Center, Golestan University of Medical Science, Gorgan, Iran.
Mousa ImeriSchool of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Amir Reza Khodanazar KaltiSchool of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Erfan Rezaie ShiraziInfectious Diseases Research Center, Golestan University of Medical Science, Gorgan, Iran.
Roghieh GolshaInfectious Diseases Research Center, Golestan University of Medical Science, Gorgan, Iran.ORCID https://orcid.org/0000-0001-8943-4849
Golestan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 has turned into a global public health crisis. This study intended to compare demographic characteristics, disease severity, treatment methods, and clinical outcomes in hospitalized patients with COVID-19 during the third and fourth waves of the pandemic in Golestan Province, Iran. Methods: In this cross-sectional study, the clinical epidemiology of all COVID-19 patients, who were hospitalized in two educational hospitals in Golestan Province for 30 days from the start of the third and fourth waves of the coronavirus pandemic in 2021-2022, was assessed. Their electronic medical records were used to collect their epidemiological, demographic, laboratory, and clinical information and treatment outcome. Results: In all, 930 electronic medical records of the hospitalized patients (351 in the third wave and 579 in the fourth wave) were studied. In the third and fourth waves, 29.06% and 13.13% of the patients had severe COVID-19, respectively ( Conclusion: The reduced rate of mortality in the fourth wave was compared to the third wave. This reduction can be attributed to the change in the national strategy adopted in terms of hospitalization criteria and treatment protocols taking into account the acquired experience, earlier hospitalization, and start of drug therapy.

Identifiers

PMID36624798
PMCPMC9825220
OpenAlexW4313340829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.